News
-
-
PRESS RELEASE
Lobe Sciences Reports Third Quarter 2026 Financial Results
Lobe Sciences Ltd. announces unaudited financial results for Q3 2026, showing progress in R&D and capital allocation. Equity position increased. Private placements closed and announced. Subsidiaries focusing on drugs for neurological and psychiatric disorders -
-
-
-
-
-
-
-
PRESS RELEASE
Lobe Sciences Directors and Management Increase Equity Ownership Through Settlement of Accrued Fees by the Issuance of Common Shares
Lobe Sciences Ltd. settles accrued management fees through issuance of common shares, strengthening ownership alignment with shareholders and maintaining strong financial position with C$4.96 million in cash and short-term investments